Capabilities
Corporate and Finance

Corporate, Europe

At the heart of Europe's financial centres, our London- and Frankfurt-based European Corporate practice advises on domestic, multi-jurisdictional, and cross-border corporate transactions. Our experience includes a focus on private equity, mergers and acquisitions, and life sciences transactions.

Our principle areas of focus include:

  • Advising corporations on European and cross-border M&A transactions, joint ventures, and reorganizations.
  • Advising on both venture capital for growth companies and private equity transactions, representing funds and other investors, and their portfolio companies and management teams.
  • Advising on equity issues and on debt issues particularly for sovereigns in the international capital markets.
  • Advising on corporate governance procedures and developments.

We act for a large number of organisations in highly regulated industries, such as financial services, biotechnology, fast-moving consumer goods, chemicals, pharmaceuticals, biologicals, healthcare, and medical devices. Our additional sector focus includes retail, for profit education, and real estate investments.

What sets us apart from other firms is our multidisciplinary approach to handling transactions—the breadth of our regulatory practices complements our transactions experience, providing a strategic advantage to our clients. We also work closely with our tax, employment, intellectual property, competition, and finance experts to provide all-round support.

Experience

Equine Clinic Grosswallstadt Sale to private equity buyer

Represented Equine Clinic Grosswallstadt on its sale to Altano Gruppe GmbH (Altano), a portfolio company of Ufenau Capital Partners.

Omega Healthcare Investors Real estate acquisition and leaseback

Advised Maryland-based publicly traded REIT on its $133 million acquisition and lease-back transaction concerning 18 care home facilities in the UK with Gold Care Holdings Limited.

Omega Healthcare Investors New and amended senior unsecured credit facilities

Advised this Maryland-based publicly traded REIT on a new $1.8 billion senior unsecured revolving and term loan credit facility, an amended and restated $250 million senior unsecured term loan credit facility and, for its subsidiary, a new $100 million senior unsecured term loan credit facility.

Diversis Capital UK Limited Acquisition of ServicePower Technologies plc
Represented client in its acquisition of a workforce management software provider.
EMK Capital LLP and Bregal Capital LLP Sale of QA Group
Represented client in the sale of an IT training company to CVC Capital Partners.
More
Overview

Email Disclaimer